Position in EDIT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$252,013
-$81,611 QoQ
Shares Held
102,030
-37.3% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$887,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. EDIT ranks #169 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in EDIT
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $252,013 | 102,030 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $333,624 | 162,744 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $445,241 | 128,312 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $299,216 | 136,008 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $175,370 | 151,182 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $236,637 | 186,329 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,721,248 | 504,765 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $854,035 | 182,877 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $956,081 | 128,852 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,180,387 | 116,524 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,642,648 | 210,596 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,780,295 | 216,318 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,559,734 | 215,136 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $887,000 | 100,000 | Put | Defined | 2023-02-13 | |
| 2022-12-31 | $2,412,675 | 272,004 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,320,286 | 189,566 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $324,360 | 26,500 | Put | Defined | 2022-11-14 | |
| 2022-06-30 | $313,495 | 26,500 | Put | Defined | 2022-08-12 | |
| 2022-06-30 | $2,198,425 | 185,835 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,187,673 | 167,596 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $504,030 | 26,500 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $4,035,253 | 151,987 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,054,976 | 220,423 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,226,952 | 198,216 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,937,372 | 141,366 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,602,663 | 151,229 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,366,046 | 84,321 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,093,937 | 70,789 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,131,538 | 57,062 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||